Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone vs Sufentanil for Postoperative Analgesia in Lung Cancer Surgery
NCT05742256Phase 1Unknown
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Mar 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of oxycodone in postoperative pain (3 arms), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoint: Numeric Rating Scale Score at Rest and Cough at 24 hours. Status: unknown.
02
Drugs
oxycodone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05742256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05742256.